The advent of immunotherapy has marked a new era in cancer treatment, offering significant
clinical benefits. Cell membrane as drug delivery materials has played a crucial role in …

Glioblastoma is the most aggressive variant of glioma, the tumor of glial origin which
accounts for 80% of brain tumors. Glioblastoma is characterized by astoundingly poor …

Nanoparticles exhibiting the localized surface plasmon resonance (LSPR) phenomenon are
promising tools for diagnostics and cancer treatment. Among widely used metal …

Adoptive T cell therapy has successfully been implemented for the treatment of cancer.
Nevertheless, ex vivo expansion of T cells by artificial antigen-presenting cells (aAPCs) …

Background CAR-T cell therapy is effective in the treatment of certain hematological
malignancies, and the expansion and functional persistence of CAR-T cells in vivo are …

Targeted nanoparticles of different origins are considered as new-generation diagnostic and
therapeutic tools. However, there are no targeted drug formulations within the composition of …

As nano-sized materials prepared by isolating, disrupting and extruding cell membranes,
cellular vesicles are emerging as a novel vehicle for immunotherapeutic drugs to activate …

Tumor-derived extracellular vesicles (EVs) are active contributors in metastasis and
immunosuppression in tumor microenvironment. At least some of the EVs carry tumor …

Chimeric antigen receptor (CAR) cell therapy is a great success and breakthrough in
immunotherapy. However, there are still lots of barriers to its wide use in clinical, including …

The identification of low-frequency antigen-specific CD4+ T cells is crucial for effective
immunomonitoring across various diseases. However, this task still encounters experimental …